期刊文献+

TNF-α和IL-10基因多态性与非霍奇金淋巴瘤相关性研究进展 被引量:4

下载PDF
导出
摘要 非霍奇金淋巴瘤( non -Hodgkin ’ s lymphoma, NHL)为一组在淋巴系统疾病中更多见,其病理形态结构、生物学特征、遗传表形均不同于霍奇金淋巴瘤(Hodgkin’s lymphoma,HL)异质性的恶性病变。近20年来, NHL成激增趋势,成为威胁人类健康的主要疾病之一。目前对于NHL发病机理的研究已经深入到分子水平。基因多态性对NHL的病因、进展、预后,鉴别诊断方面的影响逐渐成为研究热点。本文就与NHL的发病机理可能具有重要影响的相关基因肿瘤坏死因子( tumor necrosis factor , TNF )和白介素10( interleukin 10,IL-10)多态性的研究进展做一综述。
作者 边界 吴敬波
机构地区 泸州医学院
出处 《现代临床医学》 2014年第3期169-171,共3页 Journal of Modern Clinical Medicine
  • 相关文献

参考文献12

  • 1Krzysztof Warzocha,Patricia Ribeiro,Nathalie Renard,Jacques Bienvenu,Carloe Charlot,Bertrand Coiffier,Gilles Salles.Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin’s lymphomas[J].Cancer Immunology Immunotherapy.2000(9)
  • 2Sigrun R. Hofmann,Rachel Ettinger,Yong-Jie Zhou,Massimo Gadina,Peter Lipsky,Richard Siegel,Fabio Candotti,John J. O?Shea.Cytokines and their role in lymphoid development, differentiation and homeostasis[J].Current Opinion in Allergy and Clinical Immunology.2002(6)
  • 3L.M. Cunningham,C. Chapman,R. Dunstan,M.C. Bell,D.J.L. Joske.Polymorphisms in the Interleukin 10 Gene Promoter are Associated with Susceptibility to Aggressive Non-Hodgkin’s Lymphoma[J].Leukemia & Lymphoma.2003(2)
  • 4K.Bogunia‐Kubik,G.Mazur,T.Wróbel,K.Kuliczkowski,A.Lange.Interleukin‐10 gene polymorphisms influence the clinical course of non‐Hodgkin’s lymphoma[J].Tissue Antigens.2008(2)
  • 5Maria Teresa Bortolin,Rosamaria Tedeschi,Ettore Bidoli,Stefania Zanussi,Chiara Pratesi,Emanuela Vaccher,Umberto Tirelli,Paolo De Paoli.Multiplex analysis of blood cytokines as a prognostic tool in HIV related non-Hodgkin lymphoma patients: A potential role of interleukin-7[J].Cytokine.2012(1)
  • 6Azza Ibrahim,Hala Abdel Rahman,Mervat Khorshied,Rania Sami,Nelly Nasr,Ola Khorshid.Tumor necrosis factor alpha?308 and Lymphotoxin alpha+252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt[J].Leukemia Research.2011(6)
  • 7刘宏,安琨,郑劲松,陈阵,刘杰.白细胞介素-10启动子区基因多态性与非霍奇金淋巴瘤相关性的研究[J].中华肿瘤防治杂志,2012,19(16):1208-1211. 被引量:4
  • 8阿丽亚.热哈提,哈力达.亚森,顾霞,郭新红,陈瑢,迪丽娜孜.阿布来提,马瑞.不同类型淋巴瘤患者血浆TNF-α测定及其临床意义[J].新疆医科大学学报,2011,34(8):843-846. 被引量:5
  • 9肖晖,张克俭,左学兰.肿瘤坏死因子基因多态性与湖北汉族人群非霍奇金淋巴瘤发病的相关性[J].现代肿瘤医学,2011,19(3):540-543. 被引量:2
  • 10H. Dean Hosgood,Wing-Yan Au,Hee Nam Kim,Jie Liu,Wei Hu,Jovic Tse,Bao Song,Kit-fai Wong,Je-Jung Lee,Stephen J. Chanock,L. P. Siu,Mark P. Purdue,Min-ho Shin,Jinming Yu,Raymond Liang,Hyeoung-Joon Kim,Nathaniel Rothman,Qing Lan.IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations[J].International Journal of Hematology.2013(6)

二级参考文献32

  • 1杜冉,潘速跃,陆兵勋.中国汉族人群白细胞介素10启动子区基因多态性的等位基因频率[J].解剖学杂志,2006,29(6):686-689. 被引量:5
  • 2Skibola CF, Bracci PM, Nieters A, et al. Tumor necrosis factor (TNF) and lymphotoxin - alpha (LTA) polymorphisms and risk of non - Hodgkin lymphoma in the InterLymph Consortium[J]. Am J Epidemiol, 2010, 171 (3): 267- 276.
  • 3Wang SS, Purdue MP, Cerhan JR, et al. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF- kB transcription factors and non- Hodgkin lymphoma risk[J]. PLoS One, 2009, 4(4) :5360.
  • 4Jevtovic - Stoimenov T, Kocic G, Pavlovic D, et al. Polymorphisms of minor - necrosis factor - alpha - 308 and lymphotoxin - alpha + 250 : possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non - Hodgkin lymphoma mononuclear cells[ J]. Leuk Lymphoma, 2008,49( 11 ) : 2163 - 2169.
  • 5Cerhan JR, Liu - Mares W, Fredericksen ZS, et al. Genetic variation in tumor necrosis factor and the nuclear factor - kappaB canonical pathway and risk of non - Hodgkin's lymphoma [ J]. Cancer Epidemiol Biomarkers Prev, 2008 Nov, 17 ( 11 ) :3161 - 3169.
  • 6Skibola CF, Curry JD, Nieters A. Genetic susceptibility to lymphoma[J]. Haematologica, 2007, 92(7): 960-969.
  • 7Habermann TM, Wang SS, Maurer M J, et al. Host immune geue polymarphisms in combination with clinical and demographic factors predict late survival in diffuse large B - cell lymphoma patients in the pre - rituximab era [ J ]. Blood, 2008, 112 (7) : 2694 - 2702.
  • 8Lech- Maranda E, Bienvenu J, Broussais -Guillaumot F, et al. Plasma TNF - alpha and IL - 10 level - based prognostic model predicts outcome of patients with diffuse large B - cell lymphoma in different risk groups defined by the International Prognostic Index [J]. Arch Immunol Ther Exp (Warsz) , 2010 , 58(2) :131 - 141.
  • 9Spink CF,Keen LJ,Mensah FK,et al.Association between non-Hodgkin lymphoma and haplotypes in the TNF region[J].Br J Haematol,2006,133(3):293-300.
  • 10Swerdlow SH,Campo E,Harris NL,et al.WHO classification of tumors of haematopoietic and lymphoid tissues[M].Lyon:IARC Press,2008:158-334.

共引文献10

同被引文献53

  • 1王丽,刘家应,夏敏,蒋慧.儿童急性白血病Th1和Th2细胞因子的临床研究[J].上海交通大学学报(医学版),2011,31(11):1657-1660. 被引量:2
  • 2Nitto T, Sawaki K. Molecular mechanisms of the antileukemia activities of retinonid and arsenic [ J ]. J Pharmacol Sci, 2014, 126 ( 3 ) : 179-185.
  • 3Zhang X L, Komada Y, Chipeta J, et al. Intracellular cytokine profile of T cells from children with acute lymphoblastic leukemia[ J]. Cancer Immunol Immunother, 2000, 49(3) : 165 - 172.
  • 4Becker Y. Molecular immunological approaches to biotherapy of human cancers-a review, hypothesis and implications [ J ], Anticancer Res, 2006, 26(2A) : 1113 -1134.
  • 5Lan Q, Zheng T, Rothman N, et al. Cytokine polymorphisms in the Thl/Th2 pathway and susceptibility to non-Hodgkin lymphoma[ J]. Blood, 2006, 107(10): 4101 -4108.
  • 6Ratinger E, Kud S, Naamrm I, et al. 1he cytotc paential interleukin- 15- stimulated cytokine-induced killer cells against leukemia cells [ J ]. Cytotherapy, 2012, 14(1) : 91 -103.
  • 7Zhan X, Fang Y, Hu S, et al. IFN- differentially regulates subsets of Gr-1 + CDllb+ myeloid ceils in chronic inflammation[ J]. Mol Immunol, 2015, 66(2) : 451 -462.
  • 8Medina-Eeheverz J, Haile L A, Zhao F, et al. IFN- regulates survival and function of tumor-induced CD11 b + Gr-1 high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bel2al [J]. Eur J Immunol, 2014, 44(8) : 2457 -2467.
  • 9Liu X, Zhang X F, Zheng Z W, et al. The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer[ J/OL]. J Transl Med, 2004, 2(1) : 33. doi: 10. 1186/1479 - 5876 - 2 - 33.
  • 10Cining C H, Stm X, Kanwar J R, et al. A eell-e dar/nant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-ct therapy[J/OL]. Cancer cell Int, 2010, 10: 36. doi: 10. 1186/1475 - 2867 - 10 - 36.

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部